Float Short %

5.71

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

1.59

EPS Last/This Y

4.36

EPS This/Next Y

6.8

Price

228.64

Target Price

266.01

Analyst Recom

1.18

Performance Q

13.99

Relative Volume

1.98

Beta

0.43

Ticker: ASND

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ASND	209.1	0.19	0.17	14457
2025-12-29	ASND	211.02	0.20	0.17	14528
2025-12-30	ASND	209.61	0.20	0.43	14688
2025-12-31	ASND	213.33	0.20	0.86	14754
2026-01-02	ASND	213.43	0.23	0.36	15963
2026-01-05	ASND	213.17	0.25	0.55	16710
2026-01-06	ASND	209.35	0.27	3.69	17330
2026-01-07	ASND	212.9	0.29	0.24	17576
2026-01-08	ASND	208.52	0.29	0.69	17953
2026-01-09	ASND	202.78	0.30	0.50	18027
2026-01-12	ASND	208.93	0.28	0.26	19702
2026-01-13	ASND	214.96	0.27	0.05	19848
2026-01-14	ASND	217.5	0.26	0.47	20173
2026-01-15	ASND	215.25	0.26	0.00	20269
2026-01-16	ASND	205.69	0.27	2.95	19639
2026-01-20	ASND	215.28	0.28	0.12	12088
2026-01-21	ASND	216.78	0.31	0.72	12695
2026-01-22	ASND	228.67	0.31	0.42	12727
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ASND	208.89	77.7	375.5	-3.22
2025-12-29	ASND	211.10	77.7	381.8	-3.22
2025-12-30	ASND	209.48	77.7	378.3	-3.22
2025-12-31	ASND	213.29	77.7	384.0	-3.22
2026-01-02	ASND	213.29	77.7	380.2	-3.22
2026-01-05	ASND	213.24	77.7	380.3	-3.22
2026-01-06	ASND	209.30	77.7	377.4	-3.22
2026-01-07	ASND	212.44	77.7	384.7	-3.22
2026-01-08	ASND	208.65	77.7	377.1	-3.22
2026-01-09	ASND	202.82	77.7	375.7	-3.22
2026-01-12	ASND	208.86	79.0	387.7	-3.22
2026-01-13	ASND	215.04	79.0	388.0	-3.22
2026-01-14	ASND	217.44	72.2	383.9	-3.22
2026-01-15	ASND	215.27	72.2	379.4	-3.22
2026-01-16	ASND	205.76	70.0	372.5	-3.22
2026-01-20	ASND	215.45	63.9	391.1	-3.22
2026-01-21	ASND	216.76	58.1	382.2	-3.22
2026-01-22	ASND	228.64	58.1	392.6	-3.22
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ASND	0.00	1.83	5.60
2025-12-29	ASND	0.00	1.84	5.60
2025-12-30	ASND	0.00	1.84	5.60
2025-12-31	ASND	0.00	1.84	5.60
2026-01-02	ASND	0.00	1.84	5.60
2026-01-05	ASND	0.00	1.78	5.60
2026-01-06	ASND	0.00	1.78	5.60
2026-01-07	ASND	0.00	1.78	5.60
2026-01-08	ASND	0.00	1.78	5.60
2026-01-09	ASND	0.00	1.78	5.60
2026-01-12	ASND	0.00	1.78	5.60
2026-01-13	ASND	0.00	1.78	5.71
2026-01-14	ASND	0.00	1.78	5.71
2026-01-15	ASND	0.00	1.78	5.71
2026-01-16	ASND	0.00	1.78	5.71
2026-01-20	ASND	0.00	1.60	5.71
2026-01-21	ASND	0.00	1.60	5.71
2026-01-22	ASND	0.00	1.60	5.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-1.17

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

0.42

Insider Transactions

Institutional Transactions

1.6

Beta

0.43

Average Sales Estimate Current Quarter

245

Average Sales Estimate Next Quarter

277

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

0.6

Max Drawdown 5-Year %

-60.5

Target Price

266.01

P/E

Forward P/E

55.07

PEG

P/S

19.39

P/B

P/Free Cash Flow

EPS

-4.25

Average EPS Est. Cur. Y

-3.22

EPS Next Y. (Est.)

3.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-35.52

Relative Volume

1.98

Return on Equity vs Sector %

106.6

Return on Equity vs Industry %

122.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.17

EBIT Estimation

392.6

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y